News

Elizabeth Warren and Bernie Sanders just slammed the Swiss drug giant Novartis over a new controversy swirling around the world’s most expensive drug

Elizabeth Warren and Bernie Sanders are among a group of five senators who slammed Novartis’ AveXis for submitting manipulated data to the FDA ahead of the approval of its gene-therapy drug. The FDA revealed the data-manipulation issue earlier this week, saying that it affected only a small portion of product-testing […]
Elizabeth Warren and Bernie Sanders just slammed the Swiss drug giant Novartis over a new controversy swirling around the world’s most expensive drug
News

Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can’t get to the kids who need it, and what a top health-tech VC is looking to invest in

Hello, Welcome to Dispensed, Business Insider’s weekly newsletter bringing you all the stories that kept our healthcare team busy this week. While Erin Brodwin’s been out celebrating her wedding, the rest of us have been staying busy holding down the fort! Congrats, Erin!! Are you new to our newsletter? You […]
Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can’t get to the kids who need it, and what a top health-tech VC is looking to invest in
News

‘Like we were being forced to gamble with our son’s life’: Health insurers won’t pay for a $2.1 million drug for kids, and parents say they’re running out of time

A new type of therapy that treats a devastating inherited disease at the genetic level was recently approved in the US. Its $US2.1 million price tag makes the drug, Zolgensma, the most expensive in the world. Four parents of children born with the disease, called spinal muscular atrophy, told Business […]
‘Like we were being forced to gamble with our son’s life’: Health insurers won’t pay for a $2.1 million drug for kids, and parents say they’re running out of time
News

Dispensed: Introducing Business Insider’s 10 people transforming healthcare

Hello, Welcome to another dose of Dispensed, Business Insider’s weekly healthcare newsletter! Before heading out for the holiday weekend, I wanted to highlight some of the great work the healthcare team here has been pulling together. The entire Business Insider newsroom got together to compile a list of 100 people […]
Dispensed: Introducing Business Insider’s 10 people transforming healthcare
News

The top scientist at AveXis told us the ‘unique’ strength that powered its $9 billion sale to Novartis, and it could shape the future of gene therapy

The biotech AveXis develops cutting-edge “gene therapy” products that could be powerful and long-lasting medical treatments. Swiss drug giant Novartis bought the biotech for $US9 billion last year in part because AveXis had figured out how to actually make gene therapies at a big-enough scale, AveXis Chief Scientific Officer Brian […]
The top scientist at AveXis told us the ‘unique’ strength that powered its $9 billion sale to Novartis, and it could shape the future of gene therapy
News

Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.

New medications that treat disease at the genetic level, called gene therapies, are incredibly promising. They could also come with million-dollar price tags. Many more gene therapies are expected to become available in the coming years, but experts say the US health system isn’t prepared. New gene therapies could present […]
Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.
News

A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 million price tag.

A one-time treatment for a devastating rare disease could be paid for with an instalment plan as soon as this summer in Massachusetts. Novartis’s AveXis unit is involved in the discussions. Its gene therapy could cost up to $US5 million per treatment. Organisers hope the plan will ensure patients can […]
A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 million price tag.